Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPIRING antiplatelet therapy after intracerebral haemorrhage
NL-OMON60494Phase 4Recruiting
- Sponsor
- University of Edinburgh
- Start
- Oct 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of aspirin in intracerebral hemorrhage (ICH) (2 arms), sponsored by University of Edinburgh. Started Oct 2025; status: recruiting.
02
Drugs
aspirin
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NL-OMON60494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60494.